Progeny bioVentures Limited Company Profile

11:59 EST 24th November 2017 | BioPortfolio

Progeny bioVentures is a subsidiary of ANGLE Technology Ltd with the remit to establish new companies from the UK bioscience base. Progeny appraises new company opportunities, develops business plans and secures funding from venture capital and other sources. Progeny's financial return depends entirely on the success of the companies it establishes. Equity stakes are negotiated as appropriate with the scientific innovators, the technology source organisation and funding sources.

Progeny provides access to a seasoned management team with in-depth experience of company start-ups and biotech product development. As the new Company develops, Progeny is able to access a fulltime management team through ANGLE Technology.

Progeny has been granted an award under the Department of Trade and Industry’s Biotechnology Mentoring and Incubation (BMI) Challenge in collaboration with University of Bristol and supported by the Universities of Southampton and Edinburgh and the Rowett Research Institute. However, Progeny extends to all UK universities, research institutes and technology source organisations including major corporates.

The Progeny process involves:

·Appraisal and protection of intellectual property and freedom-to-operate.

·Market research, including analysis of competitors market entry barriers

·Business planning

·Company formation

·Raising finance from venture capital and non-dilutive sources.

·Commercial and general management

·Early stage partnering, including licence negotiation and technology acquisition.

·Securing permanent, experienced management to take the Company through to product launch and beyond.

For further information please contact Bill Mullen or Ioan Cleaton Jones on 01483 295830 or at


Surrey Technology CentreSurrey Research Park
United Kingdom


Phone: 44 01483 295830
Fax: 44 01483 295836

News Articles [35 Associated News Articles listed on BioPortfolio]

What GE Ventures, Sanofi-Genzyme BioVentures and Nexus Venture Partners won’t invest in

At the annual Health 2.0 conference in Silicon Valley, a panel of venture capitalists describe areas of health tech that do not appeal to them.

News Headlines, PTV News: May 11, 2010

A look at today's forthcoming news stories: GSK has stepped up its drive into emerging markets; an over the counter genetic testing kit is launched in the US, and the head of BioVentures for Global He...

Rigaku Analytical Devices to Present Expanded Contraband and Threat Identification Solutions at the 6th WCO Technology and Innovation Forum

Rigaku is a Diamond Sponsor of the World Customs Organization Technology and Innovation Forum and will present latest handheld threat identification solutions and techniques. Tokyo, Japan (PRWEB) Octo...

NeuroVia closes $14mm Series A round

NeuroVia Inc. (small-molecule therapeutics for rare CNS diseases) closed a $14mm Series A round co-led by Novartis Venture Fund and Sanofi-Genzyme BioVentures, which both added members to the company ...

Animal Study Finds High-Fat Diet in Pregnancy Increases Breast Cancer Risk Over Generations

“It is believed that environmental and life-style factors, such as diet, plays a critical role in increasing human breast cancer risk, and so we use animal models to reveal the biological mechan...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

BVGH: Bringing Innovation to Neglected Disease R&D

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Don Joseph, CEO of BioVentures for Global Health about the role of BVGH and their new ...

Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte. Limited

CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...

PubMed Articles [62 Associated PubMed Articles listed on BioPortfolio]


This article deals with the variation of radon (Rn), thoron (Tn) and their progeny concentrations expressed in terms of equilibrium equivalent concentrations (EERC and EETC), in 40 houses, in four vil...

Aubergine Controls Germline Stem Cell Self-Renewal and Progeny Differentiation via Distinct Mechanisms.

Piwi family protein Aubergine (Aub) maintains genome integrity in late germ cells of the Drosophila ovary through Piwi-associated RNA-mediated repression of transposon activities. Although it is highl...

Impact of Co-Culturing with Fractionated Carbon-Ion-Irradiated Cancer Cells on Bystander Normal Cells and Their Progeny.

The purpose of this study was to compare the biological effects of fractionated doses versus a single dose of high-LET carbon ions in bystander normal cells, and determine the effect on their progeny ...

Integrated analysis of mRNA and miRNA expression profiling in rice backcrossed progenies (BC2F12) with different plant height.

Inter-specific hybridization and backcrossing commonly occur in plants. The use of progeny generated from inter-specific hybridization and backcrossing has been developed as a novel model system to ex...

Evaluation of the separation and purification of (227)Th from its decay progeny by anion exchange and extraction chromatography.

Thorium-227 is currently undergoing evaluation as a potential radionuclide for targeted cancer therapy, and as such a high chemical purity of the material is required. To establish a reliable procedur...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Stem Cells and Tibial Fractures

The aim of this trial is to determine the safety and tolerability of expanded autologous progeny of an adult CD34+ (haemopoietic) stem cell subset when infused directly into the tibial art...

Oncology Research Information Exchange Network in Improving Genetic Screening Rate in Patients With Cancer

This research trial studies how well Oncology Research Information Exchange Network (ORIEN) works in improving genetic screening rate in patients with cancer. Implementation of Progeny Gen...

Companies [104 Associated Companies listed on BioPortfolio]

Progeny bioVentures Limited

Progeny bioVentures is a subsidiary of ANGLE Technology Ltd with the remit to establish new companies from the UK bioscience base. Progeny appraises new company opportunities, develops business plans...

Frontline BioVentures

Frontline BioVentures is a China-based premier venture capital firm specializing in investments in innovative life science companies. It focuses on business within strategic life ...

BioVentures, Inc.

BioVentures, Inc. is committed to the highest levels of scholarship through the submission of original research to peer reviewed publications and presentation of our data at scientific conferences. In...

Progeny Genetics LLC

Alpine BioVentures

Alpine BioVentures is a venture capital firm committed to investing in and building revolutionary healthcare companies. It brings a unique perspective to identify game-changing sc...

More Information about "Progeny bioVentures Limited" on BioPortfolio

We have published hundreds of Progeny bioVentures Limited news stories on BioPortfolio along with dozens of Progeny bioVentures Limited Clinical Trials and PubMed Articles about Progeny bioVentures Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Progeny bioVentures Limited Companies in our database. You can also find out about relevant Progeny bioVentures Limited Drugs and Medications on this site too.

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record